Acist Medical Systems

Acist Medical Systems, a subsidiary of the Bracco Group, is a commercial-stage medical device company focused on the diagnostic cardiology market. Its core technology platform includes the ACIST CVi contrast delivery system, the ACIST HDi high-definition IVUS imaging system, and the ACIST RXi physiology suite for fractional flow reserve (FFR) measurement. The company targets interventional cardiologists with integrated solutions aimed at reducing procedural complexity, minimizing contrast volume, and optimizing patient outcomes. With over 30 million cases performed using its CVi system, Acist has established a significant installed base and continues to innovate in catheter-based diagnostics.

Integrated platform of automated contrast delivery systems (CVi), high-definition intravascular ultrasound imaging (HDi), and physiology assessment systems for fractional flow reserve measurement (RXi with dPR algorithm).

Acist competes in the cardiology diagnostics space against major medical device companies including Philips (Volcano), Boston Scientific, Abbott Vascular, and Medtronic in intravascular imaging and physiology. Its contrast delivery systems face competition from generic syringe injectors and other automated injector brands. Differentiation is achieved through system integration, workflow focus, and unique algorithms like dPR.